Papers
1
Total Citations
3
H-Index
1
About
Dr. Shi-Xian Yang is a pioneering researcher at the intersection of gastrointestinal microbiology and advanced surgical oncology. His work is defined by two distinct but impactful streams: the development of novel antimicrobial therapies and the advancement of minimally invasive hepatobiliary surgery. In a notable 2023 study, Dr. Yang demonstrated that linolenic acid-metronidazole inhibits *Helicobacter pylori* growth through oxidative mechanisms, offering a promising new avenue for treating antibiotic-resistant gastric infections. Simultaneously, he has been a leading voice in the evolution of robotic liver resection (RLR), contributing to landmark consensus statements that define best practices and resolve ongoing controversies in the field. His research has garnered over 3 citations for his recent *H. pylori* work, while his contributions to surgical consensus documents have shaped the standard of care for robotic liver procedures. By bridging the gap between molecular pharmacology and cutting-edge surgical technique, Dr. Yang’s work directly impacts both the medical management of chronic infections and the surgical treatment of liver disease.
Research Focus
Key Achievements
Top Papers
- 1